Neisseria meningitidis PorB, a TLR2 ligand, induces an antigen-specific eosinophil recall response: Potential adjuvant for helminth vaccines?

Journal of Immunology

Volumn 179, Issue 5, 2007, Pages 3222-3230

  Burke, Jennifer M ^a   Ganley Leal, Lisa M ^a   Khatri, Asma ^a   Wetzler, Lee M ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OUTER MEMBRANE PROTEIN; PROTEIN PORB; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; ANTIGEN; CHEMOKINE; IMMUNOLOGICAL ADJUVANT; LIGAND; OVALBUMIN; PORIN; PORIN PROTEINS, NEISSERIA; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; EOSINOPHIL; HELMINTH; MALE; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; OOCYTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; EOSINOPHILIA; GENETICS; HELMINTHIASIS; IMMUNOLOGY; MAST CELL; METABOLISM; MOUSE MUTANT; PARASITOLOGY; PERITONEUM MACROPHAGE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; CHEMOKINES; EOSINOPHILIA; EOSINOPHILS; HELMINTHIASIS; HELMINTHS; LIGANDS; MACROPHAGES, PERITONEAL; MAST CELLS; MICE; MICE, KNOCKOUT; MYELOID CELLS; OVALBUMIN; PORINS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; VACCINES;

EID: 38449095416     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.5.3222     Document Type: Article

References (79)

1. Wack, A., and R. Rappuoli. 2005. Vaccinology at the beginning of the 21st century. Curr. Opin. Immunol. 17: 411-418.
2. Brusic, V., and J. T. August. 2004. The changing field of vaccine development in the genomics era. Pharmacogenomics 5: 597-600.
3. Brusic, V., J. T. August, and N. Petrovsky. 2005. Information technologies for vaccine research. Expert Rev. Vaccines 4: 407-417.
4. Pulendran, B., and R. Ahmed. 2006. Translating innate immunity into immunological memory: implications for vaccine development. Cell 124: 849-863.
5. Naylor, P. H., and J. W. Hadden. 2003. T cell targeted immune enhancement yields effective T cell adjuvants. Int. Immunopharmacol. 3: 1205-1215.
6. Pulendran, B. 2004. Modulating vaccine responses with dendritic cells and Toll-like receptors. Immunol. Rev. 199: 227-250.
7. Cook, D. N., D. S. Pisetsky, and D. A. Schwartz. 2004. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol. 5: 975-979.
8. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995.
9. Martin, M., S. M. Michalek, and J. Katz. 2003. Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect. Immun. 71: 2498-2507.
10. O'Hagan, D. T., M. L. MacKichan, and M. Singh. 2001. Recent developments in adjuvants for vaccines against infectious diseases. Biomol. Eng. 18: 69-85.
11. Weeratna, R. D., S. R. Makinen, M. J. McCluskie, and H. L. Davis. 2005. TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848). Vaccine 23: 5263-5270.
12. Massari, P., A. Visintin, J. Gunawardana, K. A. Halmen, C. A. King, D. T. Golenbock, and L. M. Wetzler. 2006. Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling. J. Immunol. 176: 2373-2380.
13. Massari, P., P. Henneke, Y. Ho, E. Latz, D. T. Golenbock, and L. M. Wetzler. 2002. Cutting edge: immune stimulation by neisserial porins is Toll-like receptor 2 and MyD88 dependent. J. Immunol. 168: 1533-1537.
14. Wetzler, L. M., Y. Ho, and H. Reiser. 1996. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J. Exp. Med. 183: 1151-1159.
15. Minetti, C. A., M. S. Blake, and D. P. Remeta. 1998. Characterization of the structure, function, and conformational stability of PorB class 3 protein from Neisseria meningitidis: a porin with unusual physicochemical properties. J. Biol. Chem. 273: 25329-25338.
16. Mackinnon, F. G., Y. Ho, M. S. Blake, F. Michon, A. Chandraker, M. H. Sayegh, and L. M. Wetzler. 1999. The role of B/T costimulatory signals in the immuno-potentiating activity of neisserial porin. J. Infect. Dis. 180: 755-761.
17. Singleton, T. E., P. Massari, and L. M. Wetzler. 2005. Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent. J. Immunol. 174: 3545-3550.
18. Latz, E., J. Franko, D. T. Golenbock, and J. R. Schreiber. 2004. Haemophilus influenzae type B-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human Toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity. J. Immunol. 172: 2431-2438.
19. Abraham, D., H. L. Rotman, H. F. Haberstroh, W. Yutanawiboonchai, R. A. Brigandi, O. Leon, T. J. Nolan, and G. A. Schad. 1995. Strongyloides stercoralis: protective immunity to third-stage larvae in BALB/cByJ mice. Exp. Parasitol. 80: 297-307.
20. Arguello, F., R. W. Furlanetto, R. B. Baggs, B. T. Graves, S. E. Harwell, H. J. Cohen, and C. N. Frantz. 1992. Incidence and distribution of experimental metastases in mutant mice with defective organ microenvironments (genotypes Sl/Sld and W/Wv). Cancer Res. 52: 2304-2309.
21. Massari, P., C. A. King, H. MacLeod, and L. M. Wetzler. 2005. Improved purification of native meningococcal porin PorB and studies on its structure/function. Protein Expr. Purif. 44: 136-146.
22. Rajan, T. V., L. Ganley, N. Paciorkowski, L. Spencer, T. R. Klei, and L. D. Shultz. 2002. Brugian infections in the peritoneal cavities of laboratory mice: kinetics of infection and cellular responses. Exp. Parasitol. 100: 235-247.
23. Ramalingam, T., B. Rajan, J. Lee, and T. V. Rajan. 2003. Kinetics of cellular responses to intraperitoneal Brugia pahangi infections in normal and immunodeficient mice. Infect. Immun. 71: 4361-4367.
24. Shelburne, C. P., M. E. McCoy, R. Piekorz, V. Sexl, K. H. Roh, S. M. Jacobs-Helber, S. R. Gillespie, D. P. Bailey, P. Mirmonsef, M. N. Mann, et al. 2003. Stat5 expression is critical for mast cell development and survival. Blood 102: 1290-1297.
25. Nakao, Y., K. Funami, S. Kikkawa, M. Taniguchi, M. Nishiguchi, Y. Fukumori, T. Seya, and M. Matsumoto. 2005. Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells. J. Immunol. 174: 1566-1573.
26. Jose, P. J., D. A. Griffiths-Johnson, P. D. Collins, D. T. Walsh, R. Moqbel, N. F. Totty, O. Truong, J. J. Hsuan, and T. J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179: 881-887.
27. Mattoli, S., M. A. Stacey, G. Sun, A. Bellini, and M. Marini. 1997. Eotaxin expression and eosinophilic inflammation in asthma. Biochem. Biophys. Res. Commun. 236: 299-301.
28. Alam, R., S. Stafford, P. Forsythe, R. Harrison, D. Faubion, M. A. Lett-Brown, and J. A. Grant. 1993. RANTES is a chemotactic and activating factor for human eosinophils. J. Immunol. 150: 3442-3448.
29. Lukacs, N. W., R. M. Strieter, C. L. Shaklee, S. W. Chensue, and S. L. Kunkel. 1995. Macrophage inflammatory protein-1α influences eosinophil recruitment in antigen-specific airway inflammation. Eur. J. Immunol. 25: 245-251.
30. Abraham, S. N., and R. Malaviya. 2000. Mast cell modulation of the innate immune response to enterobacterial infection. Adv. Exp. Med. Biol. 479: 91-105.
31. Ajuebor, M. N., A. M. Das, L. Virag, R. J. Flower, C. Szabo, and M. Perretti. 1999. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J. Immunol. 162: 1685-1691.
32. Mercer-Jones, M. A., M. S. Shrotri, M. Heinzelmann, J. C. Peyton, and W. G. Cheadle. 1999. Regulation of early peritoneal neutrophil migration by macrophage inflammatory protein-2 and mast cells in experimental peritonitis. J. Leukocyte Biol. 65: 249-255.
33. + cells through interaction with the VH3 region of IgE. J. Immunol. 164: 589-595.
34. Schramm, G., F. H. Falcone, A. Gronow, K. Haisch, U. Mamat, M. J. Doenhoff, G. Oliveira, J. Galle, C. A. Dahinden, and H. Haas. 2003. Molecular characterization of an interleukin-4-inducing factor from Schistosoma mansoni eggs. J. Biol. Chem. 278: 18384-18392.
35. Marshall, J. S. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4: 787-799.
36. Marciani, D. J. 2003. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity. Drug Discov. Today 8: 934-943.
37. Cox, J. C., and A. R. Coulter. 1997. Adjuvants - a classification and review of their modes of action. Vaccine 15: 248-256.
38. Lindblad, E. B. 2004. Aluminium adjuvants - in retrospect and prospect. Vaccine 22: 3658-3668.
39. Marsh, K., and S. Kinyanjui. 2006. Immune effector mechanisms in malaria. Parasite Immunol. 28: 51-60.
40. Verthelyi, D., and D. M. Klinman. 2003. Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates. Clin. Immunol. 109: 64-71.
41. Dillon, S., A. Agrawal, T. Van Dyke, G. Landreth, L. McCauley, A. Koh, C. Maliszewski, S. Akira, and B. Pulendran. 2004. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J. Immunol. 172: 4733-4743.
42. Re, F., and J. L. Strominger. 2004. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J. Immunol. 173: 7548-7555.
43. Lamkhioued, B., A. S. Gounni, D. Aldebert, E. Delaporte, L. Prin, A. Capron, and M. Capron. 1996. Synthesis of type 1 (IFN γ) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils. Ann. NY Acad. Sci. 796: 203-208.
44. Wetzler, L. M. 2003. The role of Toll-like receptor 2 in microbial disease and immunity. Vaccine 21(Suppl. 2):S55-S60.
45. Luhrmann, A., T. Tschernig, R. Pabst, and S. Niewiesk. 2005. Improved intranasal immunization with live-attenuated measles virus after co-inoculation of the lipopeptide MALP-2. Vaccine 23: 4721-4726.
46. Borsutzky, S., V. Fiorelli, T. Ebensen, A. Tripiciano, F. Rharbaoui, A. Scoglio, C. Link, F. Nappi, M. Morr, S. Butto, et al. 2003. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant. Eur. J. Immunol. 33: 1548-1556.
47. Jeannin, P., G. Magistrelli, L. Goetsch, J. F. Haeuw, N. Thieblemont, J. Y. Bonnefoy, and Y. Delneste. 2002. Outer membrane protein A (OmpA): a new pathogen-associated molecular pattern that interacts with antigen presenting cells-impact on vaccine strategies. Vaccine 20(Suppl. 4):A23-A27.
48. Rothenberg, M. E., and S. P. Hogan. 2005. The eosinophil. Annu. Rev. Immunol. 24: 147-174.
49. Butterworth, A. E. 1977. The eosinophil and its role in immunity to helminth infection. Curr. Top. Microbiol. Immunol. 77: 127-168.
50. Behm, C. A., and K. S. Ovington. 2000. The role of eosinophils in parasitic helminth infections: insights from genetically modified mice. Parasitol. Today 16: 202-209.
51. Le Goff, L., P. Loke, H. F. Ali, D. W. Taylor, and J. E. Allen. 2000. Interleukin-5 is essential for vaccine-mediated immunity but not innate resistance to a filarial parasite. Infect. Immun. 68: 2513-2517.
52. Rotman, H. L., W. Yutanawiboonchai, R. A. Brigandi, O. Leon, G. J. Gleich, T. J. Nolan, G. A. Schad, and D. Abraham. 1996. Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third stage larvae in BALB/cByJ mice. Exp. Parasitol. 82: 267-278.
53. Hise, A. G., K. Daehnel, I. Gillette-Ferguson, E. Cho, H. F. McGarry, M. J. Taylor, D. T. Golenbock, K. A. Fitzgerald, J. W. Kazura, and E. Pearlman. 2007. Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. J. Immunol. 178: 1068-1076.
54. Maizels, R. M., A. Balic, N. Gomez-Escobar, M. Nair, M. D. Taylor, and J. E. Allen. 2004. Helminth parasites - masters of regulation. Immunol. Rev. 201: 89-116.
55. Semnani, R. T., P. B. Keiser, Y. I. Coulibaly, F. Keita, A. A. Diallo, D. Traore, D. A. Diallo, O. K. Doumbo, S. F. Traore, J. Kubofcik, et al. 2006. Filaria-induced monocyte dysfunction and its reversal following treatment. Infect. Immun. 74: 4409-4417.
56. Taylor, M. D., L. LeGoff, A. Harris, E. Malone, J. E. Allen, and R. M. Maizels. 2005. Removal of regulatory T cell activity reverses hyporesponsiveness and leads to filarial parasite clearance in vivo. J. Immunol. 174: 4924-4933.
57. Feldmesser, M., A. Casadevall, Y. Kress, G. Spira, and A. Orlofsky. 1997. Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro. Infect. Immun. 65: 1899-1907.
58. Shin, E. H., Y. Osada, H. Sagara, K. Takatsu, and S. Kojima. 2001. Involvement of complement and fibronectin in eosinophil-mediated damage to Nippostrongylus brasiliensis larvae. Parasite Immunol. 23: 27-37.
59. Jia, G. Q., J. A. Gonzalo, A. Hidalgo, D. Wagner, M. Cybulsky, and J. C. Gutierrez-Ramos. 1999. Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions. Int. Immunol. 11: 1-10.
60. Kyan-Aung, U., D. O. Haskard, R. N. Poston, M. H. Thornhill, and T. H. Lee. 1991. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J. Immunol. 146: 521-528.
61. Symon, F. A., G. M. Walsh, S. R. Watson, and A. J. Wardlaw. 1994. Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J. Exp. Med. 180: 371-376.
62. Garcia, R. C., R. Murgia, and M. Cinco. 2005. Complement receptor 3 binds the Borrelia burgdorferi outer surface proteins OspA and OspB in an iC3b-independent manner. Infect. Immun. 73: 6138-6142.
63. Edwards, J. L., E. J. Brown, K. A. Ault, and M. A. Apicella. 2001. The role of complement receptor 3 (CR3) in Neisseria gonorrhoeae infection of human cervical epithelia. Cell. Microbiol. 3: 611-622.
64. Ishibashi, Y., S. Claus, and D. A. Relman. 1994. Bordetella pertussis filamentous hemagglutinin interacts with a leukocyte signal transduction complex and stimulates bacterial adherence to monocyte CR3 (CD11b/CD18). J. Exp. Med. 180: 1225-1233.
65. Arnaout, M. A. 1990. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 75: 1037-1050.
66. Domachowske, J. B., C. A. Bonville, K. D. Dyer, A. J. Easton, and H. F. Rosenberg. 2000. Pulmonary eosinophilia and production of MIP-1α are prominent responses to infection with pneumonia virus of mice. Cell. Immunol. 200: 98-104.
67. Merz, A. J., and M. So. 2000. Interactions of pathogenic neisseriae with epithelial cell membranes. Annu. Rev. Cell Dev. Biol. 16: 423-457.
68. Jawdat, D. M., G. Rowden, and J. S. Marshall. 2006. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J. Immunol. 177: 1755-1762.
69. Mullaly, S. C., and P. Kubes. 2007. Mast cell-expressed complement receptor, not TLR2, is the main detector of zymosan in peritonitis. Eur. J. Immunol. 37: 224-234.
70. Mullaly, S. C., and P. Kubes. 2006. The role of TLR2 in vivo following challenge with Staphylococcus aureus and prototypic ligands. J. Immunol. 177: 8154-8163.
71. Young, J. D., M. Blake, A. Mauro, and Z. A. Cohn. 1983. Properties of the major outer membrane protein from Neisseria gonorrhoeae incorporated into model lipid membranes. Proc. Natl. Acad. Sci. USA 80: 3831-3835.
72. van Putten, J. P., T. D. Duensing, and J. Carlson. 1998. Gonococcal invasion of epithelial cells driven by P: IA, a bacterial ion channel with GTP binding properties. J. Exp. Med. 188: 941-952.
73. Weel, J. F., and J. P. van Putten. 1991. Fate of the major outer membrane protein P.IA in early and late events of gonococcal infection of epithelial cells. Res. Microbiol. 142: 985-993.
74. Song, J., C. A. Minetti, M. S. Blake, and M. Colombini. 1998. Successful recovery of the normal electrophysiological properties of PorB (class 3) porin from Neisseria meningitidis after expression in Escherichia coli and renaturation. Biochim. Biophys. Acta 1370: 289-298.
75. Massari, P., S. Ram, H. Macleod, and L. M. Wetzler. 2003. The role of porins in neisserial pathogenesis and immunity. Trends Microbiol. 11: 87-93.
76. Perez-Melgosa, M., H. D. Ochs, P. S. Linsley, J. D. Laman, M. van Meurs, R. A. Flavell, R. K. Ernst, S. I. Miller, and C. B. Wilson. 2001. Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine. Eur. J. Immunol. 31: 2373-2381.
77. Gavin, A. L., K. Hoebe, B. Duong, T. Ota, C. Martin, B. Beutler, and D. Nemazee. 2006. Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling. Science 314: 1936-1938.
78. Abraham, D., O. Leon, S. Schnyder-Candrian, C. C. Wang, A. M. Galioto, L. A. Kerepesi, J. J. Lee, and S. Lustigman. 2004. Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae. Infect. Immun. 72: 810-817.
79. Ramalingam, T., L. Ganley-Leal, P. Porte, and T. V. Rajan. 2003. Impaired clearance of primary but not secondary Brugia infections in IL-5 deficient mice. Exp. Parasitol. 105: 131-139.